title: The activity of sunitinib against gastrointestinal stromal tumor seems to be distinct from its antiangiogenic effects.
authors.forename: Marco
authors.initials: M
authors.lastname: Seandel
authors.forename: Jinru
authors.initials: J
authors.lastname: Shia
authors.forename: Irina
authors.initials: I
authors.lastname: Linkov
authors.forename: Robert G
authors.initials: RG
authors.lastname: Maki
authors.forename: Cristina R
authors.initials: CR
authors.lastname: Antonescu
authors.forename: Jakob
authors.initials: J
authors.lastname: Dupont
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002455:Cell Division / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D046152:Gastrointestinal Stromal Tumors / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery*; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008875:Middle Aged; D018365:Neoplasm, Residual / Q000601:surgery; D010770:Phosphotransferases / Q000037:antagonists & inhibitors; D011758:Pyrroles / Q000627:therapeutic use*; D000077210:Sunitinib; D016896:Treatment Outcome
chemical_list: D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D007211:Indoles; D011758:Pyrroles; D010770:Phosphotransferases; D000077210:Sunitinib